Category & trade
Primary
cancer · embed-ft 0.54
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
Also (top-3)
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
Palbociclib (PD-0332991) and Ribociclib Efficacy in Special Populations: Analysis of Patient-Reported Outcomes in the MONALEESA Trials - Palbociclib CDK inhibitor
Description
Efficacy of Palbociclib (PD-0332991) and Ribociclib in Special Populations: Insights from PROs in MONALEESA Trials Keywords: Breast cancer; Cyclin-dependent kinase 4/6 inhibitors; Ribociclib; Clinical trials; Endocrine therapy; Quality of Life ABSTRACT Introduction: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors abemaciclib, Palbociclib (PD-0332991) Hydrochloride, and ribociclib radically modified the treatment of hormone receptor-positive/human epidermal growth factor 2-negative advanced [&hel
Final URL
Language
en (html)
Scanned at
2026-06-23 05:04:02